These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1843 related items for PubMed ID: 21098442

  • 21. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK, Liem SS, van der Kley F, Bergheanu SC, Wolterbeek R, Bosch J, Bootsma M, Zeppenfeld K, van der Laarse A, Atsma DE, Jukema JW, Schalij MJ.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):335-43. PubMed ID: 19642182
    [Abstract] [Full Text] [Related]

  • 22. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
    Mehilli J, Kastrati A, Schulz S, Früngel S, Nekolla SG, Moshage W, Dotzer F, Huber K, Pache J, Dirschinger J, Seyfarth M, Martinoff S, Schwaiger M, Schömig A, Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators.
    Circulation; 2009 Apr 14; 119(14):1933-40. PubMed ID: 19332467
    [Abstract] [Full Text] [Related]

  • 23. Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary intervention.
    Pels K, Schröder J, Witzenbichler B, Müller D, Morguet A, Pauschinger M, Schultheiss HP, Arntz HR.
    Eur J Emerg Med; 2008 Dec 14; 15(6):324-9. PubMed ID: 19078834
    [Abstract] [Full Text] [Related]

  • 24. ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design.
    Capodanno D, Prati F, Pawlowsky T, Ramazzotti V, Albertucci J, La Manna A, Robert G, Tamburino C.
    J Cardiovasc Med (Hagerstown); 2010 Feb 14; 11(2):130-6. PubMed ID: 19829141
    [Abstract] [Full Text] [Related]

  • 25. Effects of abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI-2 trial).
    Sejersten M, Maynard C, Clemmensen P, DANAMI-2 Investigators.
    Acute Card Care; 2006 Feb 14; 8(2):75-82. PubMed ID: 16885070
    [Abstract] [Full Text] [Related]

  • 26. Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study.
    Ohlmann P, Reydel P, Jacquemin L, Adnet F, Wolf O, Bartier JC, Weiss A, Lapostolle F, Gaultier C, Salengro E, Benamer H, Guyon P, Chevalier B, Catan S, Ecollan P, Chouihed T, Angioi M, Zupan M, Bronner F, Bareiss P, Steg G, Montalescot G, Monassier JP, Morel O.
    Circ Cardiovasc Interv; 2012 Feb 01; 5(1):69-76, S1. PubMed ID: 22319064
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
    Sciagrà R, Parodi G, Migliorini A, Valenti R, Antoniucci D, Sotgia B, Pupi A.
    Am J Cardiol; 2006 Jan 01; 97(1):48-54. PubMed ID: 16377283
    [Abstract] [Full Text] [Related]

  • 32. Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
    Marzocchi A, Manari A, Piovaccari G, Marrozzini C, Marra S, Magnavacchi P, Sangiorgio P, Marinucci L, Taglieri N, Gordini G, Binetti N, Guiducci V, Franco N, Reggiani ML, Saia F, FATA Investigators.
    Eur Heart J; 2008 Dec 01; 29(24):2972-80. PubMed ID: 18940887
    [Abstract] [Full Text] [Related]

  • 33. Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial.
    Stone GW, Witzenbichler B, Godlewski J, Dambrink JH, Ochala A, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Dizon JM, Wolff SD, Brener SJ, Mehran R, Maehara A, Gibson CM.
    Circ Cardiovasc Interv; 2013 Oct 01; 6(5):527-34. PubMed ID: 24084626
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials.
    Navarese EP, Kozinski M, Obonska K, Margheri M, Gurbel PA, Kubica J, De Luca G.
    Platelets; 2012 Oct 01; 23(4):274-81. PubMed ID: 21988317
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 93.